Enoxacin, like other fluoroquinolones, is known to trigger [[seizures]] or lower the [[seizure threshold]].<ref name="pmid8395790">{{cite journal |vauthors=De Sarro A, Zappalá M, Chimirri A, Grasso S, De Sarro GB |title=Quinolones potentiate cefazolin-induced seizures in DBA/2 mice |journal=Antimicrob. Agents Chemother. |volume=37 |issue=7 |pages=1497–503 | date=July  1993 |pmid=8395790 |pmc=188001 |doi= 10.1128/aac.37.7.1497|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=8395790 |accessdate=2014-09-25}}</ref> The compound should not be administered to patients with [[epilepsy]] or a personal history of previous convulsive attacks as may promote the onset of these disorders.<ref name="pmid2862357">{{cite journal |vauthors=Simpson KJ, Brodie MJ |title=Convulsions related to enoxacin |journal=Lancet |volume=2 |issue=8447 |pages=161 | date=July  1985 |pmid=2862357 |doi= 10.1016/s0140-6736(85)90270-3|url= }}<!--|accessdate=2014-09-24--></ref>

 

